See more : Xinhuanet Co., Ltd. (603888.SS) Income Statement Analysis – Financial Results
Complete financial analysis of Intuitive Surgical, Inc. (ISRG) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Intuitive Surgical, Inc., a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
You may be interested
- Avanti Feeds Limited (AVANTIFEED.NS) Income Statement Analysis – Financial Results
- Hubei Jumpcan Pharmaceutical Co., Ltd. (600566.SS) Income Statement Analysis – Financial Results
- Angion Biomedica Corp. (ANGN) Income Statement Analysis – Financial Results
- Erin Energy Corporation (ERINQ) Income Statement Analysis – Financial Results
- Gridwiz (453450.KQ) Income Statement Analysis – Financial Results
Intuitive Surgical, Inc. (ISRG)
About Intuitive Surgical, Inc.
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its surgical systems; progressive learning pathways to support the use of its technology; a complement of services to its customers, including support, installation, repair, and maintenance; and integrated digital capabilities providing unified and connected offerings, streamlining performance for hospitals with program-enhancing insights. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 7.12B | 6.22B | 5.71B | 4.36B | 4.48B | 3.72B | 3.13B | 2.70B | 2.38B | 2.13B | 2.27B | 2.18B | 1.76B | 1.41B | 1.05B | 874.92M | 600.83M | 372.68M | 227.34M | 138.80M | 91.68M | 72.02M | 51.67M | 26.62M | 10.19M | 0.00 |
| Cost of Revenue | 2.39B | 2.03B | 1.75B | 1.50B | 1.37B | 1.12B | 934.80M | 814.30M | 806.50M | 717.90M | 670.90M | 608.50M | 483.50M | 383.00M | 301.12M | 254.14M | 186.54M | 124.85M | 73.77M | 50.81M | 47.65M | 34.58M | 28.22M | 13.28M | 7.03M | 0.00 |
| Gross Profit | 4.73B | 4.20B | 3.96B | 2.86B | 3.11B | 2.60B | 2.19B | 1.89B | 1.58B | 1.41B | 1.59B | 1.57B | 1.27B | 1.03B | 751.05M | 620.78M | 414.29M | 247.84M | 153.57M | 87.99M | 44.03M | 37.44M | 23.46M | 13.35M | 3.16M | 0.00 |
| Gross Profit Ratio | 66.39% | 67.44% | 69.32% | 65.65% | 69.45% | 69.92% | 70.12% | 69.89% | 66.18% | 66.32% | 70.38% | 72.07% | 72.49% | 72.89% | 71.38% | 70.95% | 68.95% | 66.50% | 67.55% | 63.39% | 48.03% | 51.98% | 45.39% | 50.12% | 31.02% | 0.00% |
| Research & Development | 998.80M | 879.00M | 671.00M | 595.10M | 557.30M | 418.10M | 328.60M | 239.60M | 197.40M | 178.00M | 167.70M | 170.00M | 140.20M | 116.00M | 95.10M | 79.37M | 48.86M | 29.78M | 17.35M | 17.81M | 16.19M | 16.79M | 13.85M | 11.73M | 11.13M | 23.21M |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 986.60M | 810.90M | 705.30M | 640.50M | 691.00M | 574.00M | 522.20M | 438.80M | 358.80M | 278.51M | 230.57M | 158.69M | 110.70M | 67.44M | 48.99M | 39.72M | 40.86M | 29.99M | 19.14M | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 1.96B | 1.74B | 1.47B | 1.22B | 1.18B | 986.60M | 810.90M | 705.30M | 640.50M | 691.00M | 574.00M | 522.20M | 438.80M | 358.80M | 278.51M | 230.57M | 158.69M | 110.70M | 67.44M | 48.99M | 39.72M | 40.86M | 29.99M | 19.14M | 9.34M | 7.57M |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 4.75M | 11.58M | 7.57M |
| Operating Expenses | 2.96B | 2.62B | 2.14B | 1.81B | 1.74B | 1.40B | 1.14B | 944.90M | 837.90M | 869.00M | 741.70M | 692.20M | 579.00M | 474.80M | 373.61M | 309.94M | 207.54M | 140.48M | 84.80M | 66.81M | 55.91M | 57.66M | 43.84M | 35.62M | 22.71M | 30.77M |
| Cost & Expenses | 5.36B | 4.65B | 3.89B | 3.31B | 3.10B | 2.52B | 2.07B | 1.76B | 1.64B | 1.59B | 741.70M | 1.30B | 1.06B | 857.80M | 674.73M | 564.08M | 394.09M | 265.33M | 158.57M | 117.62M | 103.56M | 92.24M | 72.06M | 48.90M | 29.74M | 30.77M |
| Interest Income | 192.10M | 29.70M | 69.30M | 157.20M | 116.80M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 14.90M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 29.70M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 15.80M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 421.80M | 380.40M | 317.00M | 282.50M | 199.70M | 120.10M | 95.00M | 88.90M | 89.50M | 74.40M | 67.30M | 57.80M | 46.50M | 40.40M | 34.58M | 25.08M | 13.03M | 35.27M | 6.73M | 7.11M | 10.63M | 4.55M | 4.71M | 4.75M | 2.24M | 0.00 |
| EBITDA | 2.17B | 1.58B | 1.82B | 1.05B | 1.37B | 1.32B | 1.16B | 1.05B | 740.00M | 619.20M | 919.80M | 935.90M | 741.30M | 595.60M | 377.44M | 335.92M | 219.77M | 107.36M | 75.50M | 21.18M | -1.25M | -15.67M | -15.67M | -17.53M | -17.31M | -30.77M |
| EBITDA Ratio | 30.45% | 25.35% | 31.89% | 24.09% | 30.69% | 32.21% | 33.71% | 34.95% | 31.04% | 25.56% | 37.64% | 40.30% | 39.54% | 39.29% | 35.87% | 38.39% | 36.58% | 38.27% | 33.44% | 20.21% | -1.79% | -21.70% | -30.41% | -65.42% | -169.80% | 0.00% |
| Operating Income | 1.77B | 1.21B | 1.82B | 773.60M | 1.37B | 1.20B | 1.05B | 945.20M | 740.00M | 544.80M | 852.50M | 878.10M | 694.80M | 555.20M | 377.44M | 310.84M | 206.74M | 107.36M | 68.77M | 21.18M | -11.88M | -20.22M | -20.38M | -22.28M | -19.55M | -30.77M |
| Operating Income Ratio | 24.80% | 19.47% | 31.89% | 17.75% | 30.69% | 32.21% | 33.71% | 34.95% | 31.04% | 25.56% | 37.64% | 40.30% | 39.54% | 39.29% | 35.87% | 35.53% | 34.41% | 28.81% | 30.25% | 15.26% | -12.96% | -28.07% | -39.45% | -83.67% | -191.81% | 0.00% |
| Total Other Income/Expenses | 192.10M | 29.70M | 69.30M | 157.20M | 127.70M | 80.10M | 41.90M | 35.60M | 18.50M | 4.20M | 18.40M | 15.80M | 14.90M | 17.10M | 18.67M | 24.37M | 30.49M | 12.78M | 5.04M | 3.02M | 2.26M | 1.80M | 42.00K | -108.00K | 0.00 | 0.00 |
| Income Before Tax | 1.96B | 1.61B | 1.89B | 1.21B | 1.50B | 1.28B | 1.10B | 980.80M | 758.50M | 549.00M | 870.90M | 893.90M | 709.70M | 572.30M | 396.11M | 335.20M | 237.23M | 120.14M | 73.81M | 24.20M | -9.62M | -18.42M | -20.34M | -22.39M | 0.00 | 0.00 |
| Income Before Tax Ratio | 27.50% | 25.82% | 33.10% | 27.69% | 33.54% | 34.36% | 35.04% | 36.27% | 31.81% | 25.75% | 38.45% | 41.03% | 40.39% | 40.50% | 37.65% | 38.31% | 39.48% | 32.24% | 32.47% | 17.44% | -10.50% | -25.58% | -39.36% | -84.08% | 0.00% | 0.00% |
| Income Tax Expense | 141.60M | 262.40M | 162.20M | 140.20M | 120.40M | 154.50M | 436.50M | 244.90M | 169.70M | 130.20M | 199.90M | 237.30M | 214.60M | 190.50M | 163.51M | 130.89M | 92.70M | 48.09M | -20.33M | 726.00K | -2.26M | -1.80M | -3.68M | -3.75M | -1.13M | 29.44M |
| Net Income | 1.80B | 1.32B | 1.70B | 1.06B | 1.38B | 1.13B | 660.00M | 735.90M | 588.80M | 418.80M | 671.00M | 656.60M | 495.10M | 381.80M | 232.61M | 204.32M | 144.54M | 72.04M | 94.13M | 23.48M | -9.62M | -18.42M | -16.70M | -18.52M | -18.42M | -29.44M |
| Net Income Ratio | 25.24% | 21.25% | 29.85% | 24.33% | 30.80% | 30.29% | 21.09% | 27.21% | 24.69% | 19.65% | 29.62% | 30.14% | 28.17% | 27.02% | 22.11% | 23.35% | 24.06% | 19.33% | 41.41% | 16.91% | -10.50% | -25.58% | -32.32% | -69.57% | -180.68% | 0.00% |
| EPS | 5.12 | 3.72 | 4.79 | 3.02 | 3.98 | 3.31 | 1.97 | 2.13 | 1.76 | 1.26 | 1.86 | 1.83 | 1.40 | 1.08 | 0.67 | 0.58 | 0.42 | 0.22 | 0.30 | 0.08 | -0.05 | -0.11 | -0.10 | -0.17 | -0.85 | -1.81 |
| EPS Diluted | 5.03 | 3.65 | 4.66 | 2.94 | 3.85 | 3.16 | 1.89 | 2.08 | 1.73 | 1.23 | 1.86 | 1.78 | 1.37 | 1.05 | 0.66 | 0.57 | 0.41 | 0.21 | 0.28 | 0.07 | -0.05 | -0.11 | -0.10 | -0.17 | -0.85 | -1.81 |
| Weighted Avg Shares Out | 351.20M | 355.70M | 356.10M | 351.00M | 346.20M | 341.10M | 335.10M | 344.70M | 333.90M | 332.10M | 360.97M | 358.20M | 352.80M | 352.80M | 344.68M | 349.89M | 340.48M | 330.63M | 315.63M | 303.24M | 212.63M | 164.06M | 161.17M | 107.08M | 21.77M | 16.29M |
| Weighted Avg Shares Out (Dil) | 357.40M | 362.00M | 365.80M | 360.90M | 358.50M | 356.40M | 348.90M | 353.70M | 341.10M | 339.30M | 360.97M | 369.90M | 361.80M | 362.70M | 352.85M | 359.49M | 351.19M | 342.84M | 337.39M | 314.78M | 212.63M | 164.06M | 161.17M | 107.08M | 21.77M | 16.29M |
3 Red Hot Stocks Flashing Buy Signals: DVA, ISRG, SN
Stocks making new highs tend to make even higher highs, particularly when positive earnings estimate revisions hit the tape. And that's precisely what these three companies have seen.
Intuitive Surgical, Inc. (ISRG) Rises Higher Than Market: Key Facts
Intuitive Surgical, Inc. (ISRG) concluded the recent trading session at $490.93, signifying a +1.38% move from its prior day's close.
Intuitive Surgical, Inc. (ISRG) Is a Trending Stock: Facts to Know Before Betting on It
Intuitive Surgical (ISRG) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Buy These 4 Stocks For a Market Beating Portfolio
CNBC published an article in late August discussing some non-technology stocks investors were buying heading into the final months of 2024.
Intuitive Surgical, Inc. (ISRG) Sees a More Significant Dip Than Broader Market: Some Facts to Know
In the most recent trading session, Intuitive Surgical, Inc. (ISRG) closed at $476.69, indicating a -1.05% shift from the previous trading day.
Intuitive Surgical, Inc. (ISRG) Wells Fargo 2024 Healthcare Conference (Transcript)
Intuitive Surgical, Inc. (NASDAQ:ISRG ) Wells Fargo 2024 Healthcare Conference September 5, 2024 9:30 AM ET Company Participants Brandon Lamm - Investor Relations Jamie Samath - Chief Financial Officer Conference Call Participants Larry Biegelsen - Medical Device Analyst, Wells Fargo...
Intuitive Surgical Gains 40.5% Year to Date: What's Driving the Stock?
ISRG's shares gain on the back of strength in da Vinci surgical system.
Intuitive Surgical, Inc. (ISRG) Sees a More Significant Dip Than Broader Market: Some Facts to Know
The latest trading day saw Intuitive Surgical, Inc. (ISRG) settling at $481.73, representing a -0.35% change from its previous close.
Why Is Intuitive Surgical Stock Up 80%?
Intuitive Surgical (NASDAQ: ISRG) has seen solid gains of over 80% from levels of around $270 in early January 2021 to nearly $500 now, vs. an increase of about 50% for the S&P 500 over this period.
2 Top Healthcare Growth Stocks to Buy Right Now
Even as some sectors face uncertainty, healthcare spending is on the upswing. Industry powerhouse UnitedHealth Group is rising above its short-term challenges.
Source: https://incomestatements.info
Category: Stock Reports